PRPH — Prophase Labs Cashflow Statement
0.000.00%
Last trade - 00:00- $91.13m
- $95.25m
- $44.38m
- 39
- 41
- 39
- 34
Annual cashflow statement for Prophase Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.15 | -2.13 | 6.27 | 18.5 | -16.8 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.796 | -0.308 | 11.5 | 9.71 | 4.85 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.11 | -0.608 | -34.6 | -4.34 | 1.62 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.841 | -2.59 | -13.6 | 28.6 | -11.3 |
| Capital Expenditures | -0.228 | -1.69 | -4.23 | -3.92 | -3.15 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 5.77 | 0.673 | -15.4 | 1.84 | 1.79 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 5.54 | -1.02 | -19.7 | -2.08 | -1.37 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5.82 | 9.99 | 35.1 | -26 | 5.76 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.12 | 6.38 | 1.84 | 0.451 | -6.96 |